Gallant Selects DMH as Agency of Record

Gallant has named DMH its agency of record as the company prepares to expand its groundbreaking stem cell therapies for pets. The partnership supports the launch of new canine and feline products designed to improve quality of life through regenerative medicine.

Gallant is pushing the boundaries of animal health, using stem cell science to help treat disease, reduce pain, and extend mobility for pets. DMH will lead brand and marketing efforts, helping translate complex innovation into clear, compelling stories for veterinarians and pet owners alike.

“Gallant is tackling real problems with real science,” said Illinois Blasdel, DMH partner. “They chose DMH because we know how to turn innovation into impact.” 

We are proud to be trusted as Gallant’s integrated brand and creative partner and excited to help bring these therapies to market with confidence and clarity.